Chicken cytochrome P450 1A5 is the key enzyme for metabolizing T-2 toxin to 3'OH-T-2

International Journal of Molecular Sciences

Volumn 14, Issue 6, 2013, Pages 10809-10818

  Shang, Shufeng ^a   Jiang, Jun ^a   Deng, Yiqun ^a  

^a SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

Chicken CYP1A5; Metabolism; T 2 toxin

Indexed keywords

3' HYDROXY T 2 TOXIN; CYTOCHROME P450 1A; CYTOCHROME P450 1A4; CYTOCHROME P450 1A5; T 2 TOXIN; UNCLASSIFIED DRUG; 3'-HYDROXY-T-2 TOXIN; CYTOCHROME P-450 CYP1A5; RECOMBINANT PROTEIN; UNSPECIFIC MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CATALYSIS; CHICK EMBRYO; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME METABOLISM; HELA CELL; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; HYDROXYLATION; IN VITRO STUDY; LIVER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN SECONDARY STRUCTURE; ANALOGS AND DERIVATIVES; ANIMAL; BIOCATALYSIS; CHEMISTRY; CHICKEN; DRUG INACTIVATION; ELECTROSPRAY MASS SPECTROMETRY; GENETICS; HELA CELL LINE; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; BIOCATALYSIS; CHICKENS; CHROMATOGRAPHY, LIQUID; HELA CELLS; HUMANS; INACTIVATION, METABOLIC; PROTEIN STRUCTURE, SECONDARY; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; T-2 TOXIN;

EID: 84878195221     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140610809     Document Type: Article

References (30)

1. Eriksen, G.S.; Alexander, J. Fusarium Toxins in Cereals: A Risk Assessment; Nordic Council of Ministers: Copenhagen, Denmark, 1998; Volume 502, pp. 7-44.
2. Chi, M.; Robison, T.; Mirocha, C.; Behrens, J.; Shimoda, W. Transmission of radioactivity into eggs from laying hens (Gallus domesticus) administered tritium labeled T-2 toxin. Poult. Sci. 1978, 57, 1234-1238.
3. Chi, M.; Robison, T.; Mirocha, C.; Swanson, S.; Shimoda, W. Excretion and tissue distribution of radioactivity from tritium-labeled T-2 toxin in chicks. Toxicol. Appl. Pharmacol. 1978, 45, 391-402.
4. Robinson, T.; Mirocha, C.; Kurtz, H.; Behrens, J.; Chi, M.; Weaver, G.; Nystrom, S. Transmission of T-2 toxin into bovine and porcine milk. J. Dairy Sci. 1979, 62, 637-641.
5. Ueno, Y. Trichothecenes: Overview Address. In Mycotoxins in Human and Animal Health; Pathotox Publishers, Inc.: Park Forest South, IL, USA 1977; pp. 189-207.
6. Yoshizawa, T.; Sakamoto, T.; Ayano, Y.; Mirocha, C. 3'-Hydroxy T-2 and 3'-hydroxy HT-2 toxins: New metabolites of T-2 toxin, a trichothecene mycotoxin, in animals [lactating cow]. Agric. Biol. Chem. 1982, 46, 2613-2615.
7. Visconti, A.; Mirocha, C.J. Identification of various T-2 toxin metabolites in chicken excreta and tissues. Appl. Environ. Microbiol. 1985, 49, 1246-1250.
8. Yoshizawa, T.; Sakamoto, T.; Okamoto, K. In vitro formation of 3'-hydroxy T-2 and 3'-hydroxy HT-2 toxins from T-2 toxin by liver homogenates from mice and monkeys. Appl. Environ. Microbiol. 1984, 47, 130-134.
9. Wei, R.D.; Chu, F.S. Modification of in vitro metabolism of T-2 toxin by esterase inhibitors. Appl. Environ. Microbiol. 1985, 50, 115-119.
10. Ge, X.; Wang, J.; Liu, J.; Jiang, J.; Lin, H.; Wu, J.; Ouyang, M.; Tang, X.; Zheng, M.; Liao, M. The catalytic activity of cytochrome P450 3A22 is critical for the metabolism of T-2 toxin in porcine reservoirs. Catal. Commun. 2010, 12, 71-75.
11. Wang, J.; Jiang, J.; Zhang, H.; Cai, H.; Li, C.; Li, K.; Liu, J.; Guo, X.; Zou, G.; Wang, D.; et al. Integrated transcriptional and proteomic analysis with in vitro biochemical assay reveal the important role of CYP3A46 in T-2 toxin hydroxylation in porcine primary hepatocytes. Mol. Cell. Proteomics 2011, 10, doi:10.1074/mcp.M111.008748.
12. Bertz, R.J.; Granneman, G.R. Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clin. Pharmacokinet. 1997, 32, 210-258.
13. Mahajan, S.; Rifkind, A. Transcriptional activation of avian CYP1A4 and CYP1A5 by 2,3,7,8-tetrachlorodibenzo-p-dioxin: Differences in gene expression and regulation compared to mammalian CYP1A1 and CYP1A2. Toxicol. Appl. Pharmacol. 1999, 155, 96-106.
14. Gannon, M.; Gilday, D.; Rifkind, A.B. TCDD induces CYP1A4 and CYP1A5 in chick liver and kidney and only CYP1A4, an enzyme lacking arachidonic acid epoxygenase activity, in myocardium and vascular endothelium. Toxicol. Appl. Pharmacol. 2000, 164, 24-37.
15. Head, J.A.; Kennedy, S.W. Differential expression, induction, and stability of CYP1A4 and CYP1A5 mRNA in chicken and herring gull embryo hepatocytes. Comp. Biochem. Physiol. Toxicol. Pharmacol. 2007, 145, 617-624.
16. Wrighton, S.A.; VandenBranden, M.; Ring, B.J. The human drug metabolizing cytochromes P450. J. Pharmacokinet. Biopharm. 1996, 24, 461-473.
17. Kubota, A.; Iwata, H.; Goldstone, H.M.; Kim, E.Y.; Stegeman, J.J.; Tanabe, S. Cytochrome P450 1A4 and 1A5 in common cormorant (Phalacrocorax carbo): Evolutionary relationships and functional implications associated with dioxin and related compounds. Toxicol. Sci. 2006, 92, 394-408.
18. Orengo, C.A.; Michie, A.; Jones, S.; Jones, D.T.; Swindells, M.; Thornton, J.M. CATH-A hierarchic classification of protein domain structures. Structure 1997, 5, 1093-1109.
19. Wang, J.F.; Zhang, C.C.; Chou, K.C.; Wei, D.Q. Structure of cytochrome p450s and personalized drug. Curr. Med. Chem. 2009, 16, 232-244.
20. Sansen, S.; Yano, J.K.; Reynald, R.L.; Schoch, G.A.; Griffin, K.J.; Stout, C.D.; Johnson, E.F. Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2. J. Biol. Chem. 2007, 282, 14348-14355.
21. Scott, E.E.; Halpert, J.R., Structures of cytochrome P450 3A4. Trends Biochem. Sci. 2005, 30, 5-7.
22. Williams, P.A.; Cosme, J.; Ward, A.; Angove, H.C.; Vinkovi cacute, D.M.; Jhoti, H. Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 2003, 424, 464-468.
23. Sokolović, M.; Garaj-Vrhovac, V.; Šimpraga, B. T-2 toxin: incidence and toxicity in poultry. Arhiv. Za Higijenu Rada I Toksikologiju 2008, 59, 43-52.
24. Gareis, M.; Bauer, J.; Enders, C.; Gedek, B. Contamination of Cereals and Feed with Fusarium mycotoxins in European Countries. Fusarium Mycotoxins, Taxonomy and Pathogenicity; Chelkowski, J., Ed.; Elsevier Sciense Publishers BV: Amsterdam, The Netherlands, 1989; Volume 2, pp. 441-472.
25. Langseth, W.; Rundberget, T. The occurrence of HT-2 toxin and other trichothecenes in Norwegian cereals. Mycopathologia 1999, 147, 157-165.
26. Schollenberger, M.; Müller, H.-M.; Rüfle, M.; Suchy, S.; Plank, S.; Drochner, W. Natural occurrence of 16 Fusarium toxins in grains and feedstuffs of plant origin from Germany. Mycopathologia 2006, 161, 43-52.
27. Cai, H.; Jiang, J.; Yang, Q.; Chen, Q.; Deng, Y. Functional characterization of a first avian cytochrome P450 of the CYP2D subfamily (CYP2D49). PLoS One 2012, 7, e38395.
28. Burke, M.D.; Thompson, S.; Weaver, R.J.; Wolf, C.R.; Mayers, R.T. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem. Pharmacol. 1994, 48, 923-936.
29. Muchmore, D.C.; McIntosh, L.P.; Russell, C.B.; Anderson, D.E.; Dahlquist, F.W. Expression and nitrogen-15 labeling of proteins for proton and nitrogen-15 nuclear magnetic resonance. Methods Enzymol. 1989, 177, 44-73.
30. Shang, S.; Tan, S.; Li, K.; Wu, J.; Lin, H.; Liu, S.; Deng, Y. Glu659Leu substitution of recombinant HIV fusion inhibitor C52L induces soluble expression in Escherichia coli with equivalent anti-HIV potency. Protein Eng. Des. Sel. 2011, 24, 545-551.